Genitourinary Cancer News & Features
A novel immunotherapeutic approach improved outcomes for patients with advanced bladder cancer, according to a recent study.
Taking muscle-building supplements significantly increases likelihood of developing testicular cancer.
The addition of chemotherapy after bladder cancer surgery lowered risk of death by approximately 30%, over surgery alone, according to a study that reviewed patient data.
Older white males with advanced bladder cancer are the most likely to commit suicide among patients with genitourinary cancers.
Risk factors for suicide include male gender, distant disease, increasing age, race/ethnicity.
Genitourinary Cancer Clinical Trials
- Existing Drug May Limit Recurrence and Metastasis of Glioblastoma Multiforme
- New Blood Test Improves Screening for Prostate Cancer
- Nanoliposomal Irinotecan Extends Survival in Metastatic Pancreatic Cancer
- Blood Sample Offers a New Way of Detecting Cancer
- International Study Charts Genetic Trajectory for Melanoma
- Breastfeeding Associated With A Reduced Risk of Aggressive Breast Cancer
- Hospitals Should Enact Bereavement Programs, Researchers Urge
- Physical Activity Communications Should be Part of Oncology Care Clinic Visits With Patients
- Communication Practices of Many US Physicians May Be Discouraging HPV Vaccination
- Gut Bacteria Can Dramatically Amplify Cancer Immunotherapy
- FDA Approves Elotuzumab for Multiple Myeloma Combination Therapy
- Investigational Immunotherapeutic Approach Increased Survival in Patients With Bladder Cancer
- Researchers Show That Pigeons Are Adept at Interpreting Radiologic Diagnostic Images
- Rates of PSA Screening and Early Stage Prostate Cancer Are Declining
- Use of Genomic Testing in Breast Cancer Has Greater Impact on Treatment, Costs
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|